Clinical validation of the most highly significant SNPs from cell-based models may provide important insights into the genetic architecture of human response to chemotherapy, and may inform the interpretation of results from past clinical studies and the design of future studies 48 .
← all excerpts
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
1
—
—